Activation of guanylate cyclase-C attenuates stretch responses and sensitization of mouse colorectal afferents

Journal of Neuroscience

Volumn 33, Issue 23, 2013, Pages 9831-9839

  Feng, Bin ^a   Kiyatkin, Michael E ^a   La, Jun Ho ^a   Ge, Pei ^b   Solinga, Robert ^b   Silos Santiago, Inmaculada ^b   Gebhart, Gerald F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Ironwood Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; GUANYLATE CYCLASE C; UNCLASSIFIED DRUG; UROGUANYLIN;

ANIMAL TISSUE; ARTICLE; COLORECTAL AFFERENT; CONTROLLED STUDY; ELECTROMYOGRAPHY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERSENSITIVITY; IN SITU HYBRIDIZATION; MALE; MICROSCOPY; MOUSE; NONHUMAN; PELVIC NERVE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSORY NERVE; STRETCHING;

AFFERENT PATHWAYS; ANIMALS; CELL LINE, TUMOR; COLON; ENZYME ACTIVATION; GUANYLATE CYCLASE; HUMANS; MALE; MECHANORECEPTORS; MICE; MICE, INBRED C57BL; RECTUM;

EID: 84878471844     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5114-12.2013     Document Type: Article

References (32)

1. Bang S, Kim KY, Yoo S, Lee SH, Hwang SW (2007) Transient receptor potential V2 expressed in sensory neurons is activated by probenecid. Neurosci Lett 425:120-125.CrossRef Medline
2. Basu N, Arshad N, Visweswariah SS (2010) Receptor guanylyl cyclase C (GC-C): regulation and signal transduction. Mol Cell Biochem 334:67-80.CrossRef Medline
3. Bharucha AE, Linden DR (2010) Linaclotide- a secretagogue and antihyperalgesic agent- what next? Neurogastroenterol Motil 22:227-231.CrossRef Medline
4. Blackshaw LA, Brookes SJ, Grundy D, Schemann M (2007) Sensory transmission in the gastrointestinal tract. Neurogastroenterol Motil 19:1-19.CrossRef Medline
5. Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganiere M, Verrier P, Poitras P (2002) Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 122:1771-1777.CrossRef Medline
6. Brierley SM, Jones RC 3rd, Gebhart GF, Blackshaw LA (2004) Splanchnic and pelvic mechanosensory afferents signal different qualities of colonic stimuli in mice. Gastroenterology 127:166-178.CrossRef Medline
7. Bryant AP, Busby RW, Bartolini WP, Cordero EA, Hannig G, Kessler MM, Pierce CM, Solinga RM, Tobin JV, Mahajan-Miklos S, Cohen MB, Kurtz CB, Currie MG (2010) Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract. Life Sci 86:760-765.CrossRef Medline
8. Busby RW, Bryant AP, Bartolini WP, Cordero EA, Hannig G, Kessler MM, Mahajan-Miklos S, Pierce CM, Solinga RM, Sun LJ, Tobin JV, Kurtz CB, Currie MG (2010) Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit. Eur J Pharmacol 649:328-335.CrossRef Medline
9. Busby RW, Kessler MM, Bartolini WP, Bryant AP, Hannig G, Higgins CS, Solinga RM, Tobin JV, Wakefield JD, Kurtz CB, Currie MG (2013) Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation. J Pharmacol Exp Ther 344:196-206.CrossRef Medline
10. Cervetto C, Maura G, Marcoli M (2010) Inhibition of presynaptic releasefacilitatory kainate autoreceptors by extracellular cyclic GMP. J Pharmacol Exp Ther 332:210-219.CrossRef Medline
11. Chey WD, Lembo AJ, Lavins BJ, Shiff SJ, Kurtz CB, Currie MG, MacDougall JE, Jia XD, Shao JZ, Fitch DA, Baird MJ, Schneier HA, Johnston JM (2012) Linaclotide for irritable bowel syndrome with constipation: a 26- week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol 107:1702-1712.CrossRef Medline
12. Eutamene H, Bradesi S, Larauche M, Theodorou V, Beaufrand C, Ohning G, Fioramonti J, Cohen M, Bryant AP, Kurtz C, Currie MG, Mayer EA, Bueno L (2010) Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain. Neurogastroenterol Motil 22:e312-e384.CrossRef Medline
13. Feng B, Gebhart GF (2011) Characterization of silent afferents in the pelvic and splanchnic innervations of the mouse colorectum. Am J Physiol Gastrointest Liver Physiol 300:G170-G180.CrossRef Medline
14. Feng B, Brumovsky PR, Gebhart GF (2010) Differential roles of stretchsensitive pelvic nerve afferents innervating mouse distal colon and rectum. Am J Physiol Gastrointest Liver Physiol 298:G402-G409.CrossRef Medline
15. Feng B, Kiyatkin ME, La J-H, Gebhart GF (2012a) Cyclic guanylate monophosphate (cGMP) attenuates responses and sensitization of mouse colorectal afferents. Gastroenterology 142[Suppl 1]:S-698. CrossRef
16. Feng B, La JH, Schwartz ES, Gebhart GF (2012b) Neural and neuroimmune mechanisms of visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 302:G1085-G1098.CrossRef Medline
17. Feng B, La JH, Schwartz ES, Tanaka T, McMurray TP, Gebhart GF (2012c) Long-term sensitization of mechanosensitive and -insensitive afferents in mice with persistent colorectal hypersensitivity. AmJ Physiol Gastrointest Liver Physiol 302:G676-G683.CrossRef Medline
18. Hughes PA, Brierley SM, Martin CM, Brookes SJ, Linden DR, Blackshaw LA (2009) Post-inflammatory colonic afferent sensitisation: different subtypes, different pathways and different time courses. Gut 58:1333-1341.CrossRef Medline
19. Johnston JM, Kurtz CB, Macdougall JE, Lavins BJ, Currie MG, Fitch DA, O'Dea C, Baird M, Lembo AJ (2010) Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. Gastroenterology 139:1877-1886.e2.CrossRef Medline
20. Jones RC 3rd, Xu L, Gebhart GF (2005) The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3. J Neurosci 25:10981-10989.CrossRef Medline
21. Jones RC 3rd, Otsuka E, Wagstrom E, Jensen CS, Price MP, Gebhart GF (2007) Short-term sensitization of colon mechanoreceptors is associated with long-term hypersensitivity to colon distention in the mouse. Gastroenterology 133:184-194.CrossRef Medline
22. Kyloh M, Nicholas S, Zagorodnyuk VP, Brookes SJ, Spencer NJ (2011) Identification of the visceral pain pathway activated by noxious colorectal distension in mice. Front Neurosci 5:16. Medline
23. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.CrossRef Medline
24. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA (2000) Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52:375-414.Medline
25. Mihara H, Boudaka A, Shibasaki K, Yamanaka A, Sugiyama T, Tominaga M (2010) Involvement of TRPV2 activation in intestinal movement through nitric oxide production in mice. J Neurosci 30:16536-16544.CrossRef Medline
26. Rao S, Lembo AJ, Shiff SJ, Lavins BJ, Currie MG, Jia XD, Shi K, MacDougall JE, Shao JZ, Eng P, Fox SM, Schneier HA, Kurtz CB, Johnston JM (2012) A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol 107:1714-1724; quiz p.1725. Medline
27. Sager G (2004) Cyclic GMP transporters. Neurochem Int 45:865-873.CrossRef Medline
28. Swenson ES, Mann EA, Jump ML, Witte DP, Giannella RA (1996) The guanylin/ STa receptor is expressed in crypts and apical epithelium throughout the mouse intestine. Biochem Biophys Res Commun 225:1009-1014.CrossRef Medline
29. Verne GN, Robinson ME, Vase L, Price DD (2003) Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain 105:223-230.CrossRef Medline
30. Verne GN, Sen A, Price DD (2005) Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome. J Pain 6:493-496.CrossRef Medline
31. Zagorodnyuk VP, Brookes SJ, Spencer NJ (2010) Structure-function relationship of sensory endings in the gut and bladder. Auton Neurosci 153: 3-11.CrossRef Medline
32. Zhou Q, Price DD, Verne GN (2008) Reversal of visceral and somatic hypersensitivity in a subset of hypersensitive rats by intracolonic lidocaine. Pain 139:218-224.CrossRef Medline